Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT From Elan
16-Mar-2010 -
Azur Pharma Limited announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion).
PRIALT is indicated in the United States for the management of severe chronic ...
Elan
patents
severe chronic pain